Other antidepressants
• Mental health and Psychiatry articles •
Apr 18, 2005
|
Tweet
|
|
These antidepressants do not fit into the aforementioned groups and many of them are newer agents.
- Edronax (Reboxetine) launched in South Africa during 2000. This inhibits noradrenaline reuptake and there is more neurotransmitter available in the synaptic cleft. Generally considered to be an energising antidepressant. It may cause insomnia, dry mouth, vertigo and some sedation initially. Not a good choice if there is a high level of anxiety associated with the depression;
- Efexor (Venlafaxine) This is a serotonin and nofadrenaline reuptake inhibitor. It is usually an energising drug with side effects similar to SSRI’s. There is a newer slow-release preparation which has fewer side effects and seems to be less likely to cause sleep disturbance;
- Lantanon (Mianserin) classified as a tetracyclic. Affects noradrenaline but via a different mechanism to the tricyclics. This is a sedative antidepressant, which is taken at night useful if insomnia is a prominent complaint. Also useful if low blood pressure is a problem as it tends not to exacerbate this, unlike the tricyclics. May cause weight gain;
- Molipaxin (Trazodone) a triazolopyridine antidepressant unrelated to any of the aforementioned antidepressants. It affects the serotonin neurotransmitter system working on pre- and postsynaptic neurones (SSRI’s exert their effects on presynaptic neurones only). The main side effect is sedation. Priapism (sustained penile erection) has been reported and may result in irreversible impotence, but this is not a common side effect;
- Remeron (Mirtazapine) belongs to a new class of antidepressant called NASSAs (noradrenaline and serotonin specific antagonists). Particularly useful if anxiety and insomnia are problems. Side effects include sedation and weight gain.
Provided by ArmMed Media
Revision date: July 9, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
Revision date: July 9, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.


